Complete Story

2005 OPA Annual ConferenceEducational Offerings - Course Descriptions

CE Credit per Program: 0.2 CEU

FRIDAY, April 15

  • 8:30 a.m.
    Applying the New Guidelines for the Treatment of Hypertension
    Anthony Restuccio, M.D., Buchanan Medical Arts, Westerville, OH
    This session will describe the new JNC VII guidelines for hypertension, how they apply to specific patient populations, and the polypharmacy aspects of hypertension treatment. Using a case-study format, pharmacists will be able to apply the ALLHAT and HOPE study results and guidelines to patient counseling.
    ACPE #129-000-05-014-L01

    Medication Therapy Management Services by Pharmacists
    Patty Kumbera, R.Ph., Outcomes Pharmaceutical Health Care
    This session is designed to describe Medication Therapy Management Services (MTMS) as it relates to the pharmacy components of health care today and its impact on Medicare Part D in 2006. Outcomes systems, where pharmacists identify, resolve, document, and bill for MTMS, will be evaluated. New revenue opportunities for your pharmacy practice will also be explored.
    ACPE #129-000-05-015-L04

    What You Should Know before Providing Care and Compounds to Animal Patients
    Gigi Davidson, R.Ph., DICVP, Director of Clinical Pharmacy Services, NC State University College of Veterinary Medicine
    This program will teach pharmacists the need for compounded veterinary products, review the medically necessary bulk chemicals, explain the current regulatory environment, and describe current initiatives to close the gap between regulation and need for veterinary compounding.
    ACPE #129-000-05-016-L04
    Sponsor: Spectrum Pharmacy Products

    Safe Medication Use in Recovering Addicts

    Nick Kallis, R.Ph. and Michael Quigley, R.Ph., PRO, Inc.
    Persons recovering from addiction experience pain, anxiety, sleep disorders, allergies, etc. This session will include a discussion of prescription, OTC, and herbal medications that may be safely used in this patient population. The disease of addiction, definitions of terms used, how to identify someone experiencing drug or alcohol addiction, and referral resources will be detailed.
    ACPE #129-000-05-017-L01
    Sponsor: PRO, Inc.

  • 10:30 a.m.
    Using Technology to Respond to New Medicare Pharmacist Provider Opportunities

    Bill G. Felkey, Professor of Pharmacy Care Systems, Auburn University
    The pharmacy profession has been named by the Centers for Medicare & Medicaid Services (CMS) as a provider that may bill Medicare for Medication Therapy Management Services (MTMS) and for Chronic Care Improvement Programs (CCIP). Any scenario for the provision of these services will include the appropriate use of technology to assure efficiency and effectiveness. This highly interactive program will assist attendees in understanding the technological options for rendering this care.
    ACPE #129-000-05-018-L04

    Complexities of Caring for People with Neuropathic Pain
    Deanna Maynard, Pharm.D., BCPS
    Medical Liaison, Purdue Pharma, L.P.

    This session will provide an overview of pain, including barriers to appropriate pain management, pathophysiology of pain, and components of a comprehensive, multidimensional pain assessment. Neuropathic pain will be explored in detail. The rational use of medications such as anticonvulsants, tricyclic antidepressants and opioids will be discussed, as well as other therapeutic options.
    ACPE #129-000-05-019-L01
    Sponsor: Purdue Pharma, L.P.

    OTC Products: What Pharmacists are Recommending

    Andrea Wall, R.Ph., Assistant Professor of Pharmacy Practice, UC; and Kristin Casper, R.Ph., Pharm.D., Assistant Professor of Clinical Pharmacy, OSU
    This program will look at the latest Pharmacy Today survey evaluating pharmacists' top picks for OTC medications. Audience members will have the opportunity to compare their recommendations, via an audience response system, with those of the survey participants and discuss the criteria used to make recommendations to patients for self-treatable conditions. New products within each OTC category will also be presented.
    ACPE #129-000-05-020-L01
    Sponsor: Procter & Gamble

    New Hope for GERD

    William Emlich, Jr., D.O.
    Consolidated Medical Specialists, Inc.
    This session will provide an overview of gastroesophageal reflux disease (GERD), its diagnosis, as well as atypical symptoms such as asthma, chronic cough, and laryngitis. Available treatment options will be discussed, including pharmacology, dosing, and side effects of prescription and OTC medications. A new endoscopic treatment for GERD will be also be presented.
    ACPE #129-000-05-021-L01
  • 2:00 p.m.
    Ohio Research Forum 2005

    Moderator: Curtis Black, R.Ph., Ph.D.
    Professor of Clinical Pharmacy, UT College of Pharmacy

    Each year dozens of Ohio pharmacists, college faculty, pharmacy residents, and students are involved in cutting-edge research. Come watch as they present their studies in a platform format. Learn more about other research projects by visiting the Poster Session which immediately follows in the Exhibit Hall.
    ACPE #129-000-05-022-L01
    Sponsor: Procter & Gamble

    PBMs 101: A No Nonsense Guide to Pharmacy Benefit Managers

    Mark S. Riley, Pharm.D.
    Executive Vice President, Arkansas Pharmacists Association

    This session will provide an overview of the history and development of pharmacy benefit managers (PBMs), as well as various "spread" tactics and rebate strategies that are used by PBMs to increase their profits. The actual flow of money as related to overall costs to employers, and the gross profits of both community pharmacy and mail order will be discussed.
    ACPE #129-000-05-023-L04

    Legal, Regulatory, and Professional Liability Considerations in Compounding
    Karen E. Peterson, R.Ph., J.D.
    Attorney, Pharmacists Mutual Insurance Company

    FDA, as well as state boards of pharmacy, regulate compounding by pharmacists as this practice expands across the country. Our attorney-pharmacist speaker will describe the current standards for compounding and professional liability concerns, and apply these standards to claims scenarios.
    ACPE #129-000-05-024-L04

    The Link Between Sleep and Headache
    Frank O'Donnell, D.O., OrthoNeuro, Westerville, OH
    This session will examine the temporal relationship between sleep and headache disorders and review the sleep disorders associated with headache. Through case presentations, the prevalence of morning headache in migraine sufferers, the role that sleep deprivation and excess play in headache, and the biologic alarm clock of patients with cluster headaches will be emphasized. The speaker will also review pharmacologic and nonpharmacologic treatment of sleep disorders and headaches.
    ACPE #129-000-05-025-L01

    SATURDAY, April 16

  • 8:30 a.m.
    Ohio Law Update 2005

    (repeated at 10:30 a.m.)
    Timothy Benedict, R.Ph., Assistant Executive Director, Ohio State Board of Pharmacy
    This important session for all pharmacists will address recent changes in state and federal laws and regulations which impact the practice of pharmacy. Topics will include the Dangerous Drug Database, drug repository program, charitable pharmacies, and the use of drug samples. This program has been approved by the State Board of Pharmacy for 0.2 CEU of Ohio jurisprudence CE credit.
    ACPE #129-000-05-026-L03

    Promoting Public Perception of Pharmacy
    Joseph Dula, Pharm.D. Candidate - The Ohio State University
    This session will explore ways in which pharmacists can become more involved in their community, and highlight key areas to focus on to positively influence public awareness and education. Presentation skills and resources for preparing programs will also be discussed.
    ACPE #129-000-05-027-L04

    Psychological Trauma: A Developmental Perspective
    Randy A. Sansone, M.D., Professor, Psychiatry & Internal Medicine, Wright State University School of Medicine
    Various psychiatric syndromes may emerge in the aftermath of trauma, including mood and anxiety disorders, borderline personality, and posttraumatic stress disorder (PTSD). This presentation will examine the similarities and differences in psychopathological outcome between trauma in childhood versus adulthood. The primary pharmacotherapy intervention in trauma and the role of benzodiazepines in the treatment of trauma will also be discussed.
    ACPE #129-000-05-028-L01
    Sponsor: Pfizer Roerig

    Medicare Modernization Update

    Elizabeth Cepero, J.D., LL.M.
    U.S. Department of Health and Human Services, CMS

    A representative from the Centers for Medicare & Medicaid Services (CMS) will address the provisions of Medicare Part D, outpatient prescription drug benefit coverage, resulting from the Medicare Prescription Drug, Improvement and Modernization Act (MMA) of 2003. Our speaker will describe the value of the pharmacist in explaining the drug discount card program to patients and in helping them receive benefits.
    ACPE #129-000-05-029-L04

    10:30 a.m.

    Ohio Law Update 2005

    (repeat of 8:30 a.m. program)

    Drug Therapy of Hyperlipidemia Based on Pharmacologic Mechanisms
    Jon E. Sprague, R.Ph., Ph.D., Associate Professor of Pharmacology, Virginia College of Osteopathic Medicine, Virginia Tech University
    Drug therapy of hyperlipidemia varies drastically from the use of statins to niacin. The pharmacologic rationale for drug therapy will be reviewed based on drug mechanisms and the pathophysiology of hyperlipidemia. This program is intended to be a review of the fundamental pharmacological mechanisms of drugs affecting blood lipids. The National Cholesterol Education Program (NCEP) guidelines will also be presented.
    ACPE #129-000-05-030-L01

    Women with HIV/AIDS
    Patty Havard, Pharm.D.
    Associate Professor, OSU College of Pharmacy and College of Medicine and Public Health, Dept. of OB/GYN
    The World Health Organization estimates that the AIDS epidemic is affecting women and girls in increasing numbers. This presentation will focus on recent data on gender differences in disease progression and illness associated with HIV/AIDS, gender-specific pharmacokinetics and side effects of antiretroviral therapy, and current treatment guidelines in the management of HIV in nonpregnant and pregnant women.
    ACPE #129-000-05-031-L02

    Clinical Pearls to Prevent
    Pharmacy Perils

    Vincent F. Mauro, Pharm.D., FCCP Professor of Clinical Pharmacy, UT College of Pharmacy
    This session will focus on drug interactions, adverse events, and dosing issues in patients using commonly prescribed medications in both community and hospital settings. Using a case study format, our speaker will teach pharmacists how to identify medications that require dosage adjustments in patients with renal dysfunction; to recognize unique drug interactions; and to circumvent complications that arise.
    ACPE #129-000-05-032-L01
  • 2:30 p.m.
    Implementing Specialized Pharmacy Services via Community Pharmacy Residency Programs

    Michael T. Rupp, Ph.D., Professor and Executive Director, Center for Advancement of Pharmacy Practice, Midwestern University, Glendale, AZ
    Community Pharmacy Residency Programs (CPRP) can be valuable in implementing specialized pharmacy services. Our speaker will describe the process of program planning for specialized services at a CPRP practice site; share examples of specialized services that have been implemented; and evaluate alternative services to ensure optimal fit between the mission of the pharmacy, the objectives of the preceptor, the interests of the resident, the needs of patients, and the resource demands on the practice.
    ACPE #129-000-05-033-L04

    Disorders of Initiating and Maintaining Sleep: The Etiology and Management of Insomnia
    Markus H. Schmidt, M.D., Ph.D., Director of Research, Ohio Sleep Medicine Institute, Dublin, OH
    More than 49 percent of the population suffers from insomnia, characterized by difficulty falling asleep and/or staying asleep. Insomnia is usually a symptom of another sleep disorder, but can be triggered by psychological factors, lifestyle change, or physical illness. This session will provide an overview of insomnia, and available treatment options, including pharmacologic and nonpharmacologic interventions.
    ACPE #129-000-05-034-L01
    Sponsor: Sepracor

    Physical Activity: Rx for Better Health

    William Richards, Ph.D. Candidate
    Sport and Exercise Science Program, The Ohio State University

    This presentation will offer information, beneficial to both pharmacists and their patients, regarding the body's need for physical activity, and the many health and fitness benefits that can be derived from even modest amounts of regular activity. The goal of this session is to encourage and empower pharmacists to take positive steps towards increased physical activity, and to become a role model for their patients.
    ACPE #129-000-05-035-L04

    Fundamentals of Diabetes and the Role of Insulin
    Bryan Feldman, D.O., Parsons Avenue Medical Clinic, Columbus, OH
    This session will review the causes and characteristics of Type 1 and Type 2 diabetes, common complications associated with diabetes, and treatment goals for monitoring glycemic control. The appropriateness of insulin use in Type 2 diabetes, the difference between human and analog molecule insulins, the practical aspects of insulin use, and the advantages of prefilled syringes, as well as how to use them, will be presented.
    ACPE #129-000-05-036-L01
    Sponsor: Novo Nordisk

    SUNDAY, April 17
  • 8:30 a.m.
    Medicaid Update 2005

    Stephen Mueller, M.S., R.Ph.
    First Health Services Corp.

    The Medicaid program has undergone many recent changes, with more on the way. This session will deal with the Preferred Drug List, and various edits in the Medicaid program. Bring your questions about the changes in Medicaid that affect your practice.
    ACPE #129-000-05-037-L04

    Issues in Parkinson's Disease: Pharmacotherapy, Psychotherapy, and Patient Management
    David Purdy, R.Ph., Pharmacist and Patient
    OPA member David Purdy, R.Ph. had to give up his practice of pharmacy in 1987 due to Parkinson’s Disease. Since then, he has spoken to health professionals and patients on drug and non-drug therapy, the psychological aspects of the disease, and how to treat the patients with compassion. He will address possible causes of the disease, new drug therapies and routes of administration, psychological issues experienced by patients, and how to effectively manage them.
    ACPE #129-000-05-038-L01
    Sponsor: Teva Neuroscience

    The Role of the Pharmacist in Wellness and Prevention

    Carrie Fish, R.Ph., Pharm.D., Ambulatory Care Pharmacy Practice Resident, OSU College of Pharmacy
    As one of the most accessible health care professionals, the pharmacist has a unique opportunity to promote wellness and prevention through assessment of health risks, screenings, newsletters, and more. Discussion will center around disease states well-suited for pharmacist intervention (i.e., hypertension, diabetes), and the role the pharmacist can play in keeping the public healthy.
    ACPE #129-000-05-039-L04
  • 10:30 a.m.
    Update on New Drugs 2005

    Karen L. Kier, Ph.D., M.Sc., R.Ph.
    Professor of Clinical Pharmacy Director, Drug Information,ONU College of Pharmacy
    In this annual new drug update, our speaker will examine the pharmacology and therapeutics of the medications released in the past year. The drugs' indications, adverse effects, drug interactions, as well as useful patient counseling tips will be outlined. A great deal of practical and immediately applicable information will be included in this presentation.
    ACPE #129-000-05-040-L01

    Together We Prepare
    American Red Cross Instructor
    Many Americans are not sufficiently prepared for emergencies at work or at home. Together We Prepare™ is a nationwide initiative to help communities prepare for emergencies and disasters before they happen. This presentation will include first aid and emergency preparedness that pharmacists can apply to any situation. Attendees will also learn five steps they can share with their patients to help make their families, workplaces, schools, and neighborhoods safer: make a plan, build a kit, get trained, volunteer, give blood.
    ACPE #129-000-05-041-L04

    Legal Issues in Pharmacy
    Mary Beth Levine, Esq., Benesch, Friedlander, Coplan & Aronoff LLP
    This session will provide an overview of situations in which pharmacists may be faced with having to make decisions regarding legal documents or requests from attorneys, members of the government and law enforcement. Our speaker will discuss how to best handle search warrants and subpoenas, understand legal requests, and make informed decisions about how to respond to various legal inquiries in the pharmacy and enforcement areas.
    ACPE #129-000-05-042-L04
  • 1:00 p.m.
    Adult CPR with Automated External Defibrillator

    Red Cross Instructors 0.45 CEU
    This 4.5 hour course will provide CPR with AED certification.
    ACPE #129-000-04-043-L04

Printer-Friendly Version